High treatment efficacy by dual targeting of Burkitt's lymphoma xenografted mice with a (177)Lu-based CD22-specific radioimmunoconjugate and rituximab.
about
High treatment efficacy by dual targeting of Burkitt's lymphoma xenografted mice with a (177)Lu-based CD22-specific radioimmunoconjugate and rituximab.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
High treatment efficacy by dua ...... immunoconjugate and rituximab.
@en
type
label
High treatment efficacy by dua ...... immunoconjugate and rituximab.
@en
prefLabel
High treatment efficacy by dua ...... immunoconjugate and rituximab.
@en
P2093
P2860
P1476
High treatment efficacy by dua ...... oimmunoconjugate and rituximab
@en
P2093
Anne Schlegelmilch
Armin Keller
Benedikt Bötticher
Dirk Jäger
Jürgen Krauss
Karin Leotta
Ludger Grosse-Hovest
Michaela A E Arndt
Susanne Krämer
Tobias Weber
P2860
P2888
P304
P356
10.1007/S00259-015-3175-6
P577
2015-09-04T00:00:00Z